The landscape of molecular chaperones across human tissues reveals a layered architecture of core and variable chaperones by Shemesh, N. et al.
ARTICLE
The landscape of molecular chaperones across
human tissues reveals a layered architecture
of core and variable chaperones
Netta Shemesh1,2,4, Juman Jubran1,4, Shiran Dror 2, Eyal Simonovsky 1, Omer Basha1, Chanan Argov1,
Idan Hekselman1, Mehtap Abu-Qarn2, Ekaterina Vinogradov1, Omry Mauer1, Tatiana Tiago 3, Serena Carra 3,
Anat Ben-Zvi 2✉ & Esti Yeger-Lotem 1✉
The sensitivity of the protein-folding environment to chaperone disruption can be highly
tissue-specific. Yet, the organization of the chaperone system across physiological human
tissues has received little attention. Through computational analyses of large-scale tissue
transcriptomes, we unveil that the chaperone system is composed of core elements that are
uniformly expressed across tissues, and variable elements that are differentially expressed to
fit with tissue-specific requirements. We demonstrate via a proteomic analysis that the
muscle-specific signature is functional and conserved. Core chaperones are significantly more
abundant across tissues and more important for cell survival than variable chaperones.
Together with variable chaperones, they form tissue-specific functional networks. Analysis of
human organ development and aging brain transcriptomes reveals that these functional
networks are established in development and decline with age. In this work, we expand the
known functional organization of de novo versus stress-inducible eukaryotic chaperones into
a layered core-variable architecture in multi-cellular organisms.
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Chaperones are highly conserved molecular machines thatcontrol cellular protein homeostasis (proteostasis). Acrossspecies, they promote de novo protein folding and protein
maturation1, protein translocation2, protein-complexes assembly
and disassembly3, protein disaggregation and refolding4, and
protein degradation5. In accordance with their fundamental roles,
chaperones are abundant proteins. In human cell lines, for
example, they were shown to compose ~10% of the total pro-
teome mass6.
Chaperones have been grouped into families based on their
molecular mass, common domains, protein structure similarity,
and common function1. Families composing the main chaperone
machinery, which modulate protein structure without partici-
pating in the final protein complex, include prefoldin7, the small
heat shock proteins (sHSP)8, and the main ATP-hydrolyzing
chaperones, HSP609, HSP7010, HSP9011, and HSP10012. Families
of co-chaperones modulate the activity of main chaperones by
regulating their ATPase cycle or the recognition, binding, or
release of chaperone substrates, and include HSP109, HSP40
(DNAJ)13, nuclear exchange factors (NEFs)14, and co-HSP9015.
Folding enzymes that catalyze folding-accelerating reactions, such
as peptidyl prolyl cis–trans isomerization or protein disulfide
isomerization16,17, are also considered as chaperones.
The chaperone system is highly versatile. Most chaperones
interact with multiple co-chaperones, and co-chaperones can
interact with multiple chaperones, thereby modifying their
function or the fate of their substrates. For example, the same
HSP70 chaperone can interact with different HSP40 co-chaper-
ones, altering its substrate specificity13. Likewise, co-chaperones
containing the TPR domain, such as Hop, interact with both
HSP70 and HSP90, thereby targeting substrates for either folding
or degradation, respectively18. The versatility and robustness of
the chaperone system manifests in stress conditions, which lead
to extensive upregulation of some chaperones. However, the
system also has limitations. Whereas chaperone overexpression
typically improves the folding capacity of the chaperone system,
overexpression of specific chaperones was shown to disrupt
folding19–23. For example, overexpression of the folding enzyme
FKBP51 in a tau transgenic mouse model resulted in accumula-
tion of tau and its toxic oligomers21. Likewise, chaperone
downregulation or genetic aberration can cause diseases, such as
mutation in the NEF co-chaperone BAG3 that leads to
myopathy24. These observations imply that the quantitative
composition of the chaperone system can improve or impair its
proteostatic capacity.
The chaperone system has expanded considerably in
evolution25,26. The HSP40 family, for example, expanded from
three members in E. coli and 22 members in budding yeast to 49
members in human, whose distinct functionalities are not totally
clear13. The evolution of the sHSP family is more complex, as
plants and some lower eukaryotes have more sHSPs than mam-
malian and higher eukaryotes27. Consequently, the chaperone
system has been remodeled. Whereas in prokaryotes the same
chaperones carry both de novo protein folding and response to
stress, unicellular eukaryotes evolved two separately regulated
chaperone systems, a basal system and a stress inducible system,
each composed of distinct members of the same chaperone
families28. This two-level organization is conserved in multi-
cellular eukaryotes. Yet, multi-cellular eukaryotes are also com-
posed of multiple cell types, tissues, and organs, each having
different proteomes and thus potentially different folding
demands. For example, HSPB1 is required for actin and myofibril
assembly and its depletion specifically impairs cardiac progenitor
fusion and heart tube formation29.
Recent years were marked by multiple large-scale mappings of
the proteomic and transcriptomic landscapes of tens of human
tissues. Major efforts included the Human Protein Atlas (HPA)30,
Fantom531, and the Genotype Tissue Expression (GTEx)
consortium32. These resources enabled unprecedented quantita-
tive views into the genes and proteins that make up physiological
human tissues. These studies and others have revealed tissue-
specific regulatory elements, molecular interaction networks, and
functional mechanisms underlying traits and diseases32–36. Large-
scale studies of the chaperone system were performed in the
context of neurodegenerative diseases37, heat stress38, and
cancer39 via analysis of samples gathered from patients. These
studies revealed different patterns of chaperone network dysre-
gulation. However, a systematic examination of the basal cha-
perone network in physiological human tissues has been lacking.
In this work, we harness transcriptomic profiles gathered by
the GTEx consortium32, as well as other publicly available omic
datasets30,37,40–43, to systematically examine the basal chaperone
system in various human tissues. We focus on 194 manually
curated chaperones, co-chaperones, and folding enzymes of
the main chaperone families, henceforth collectively referred to as
chaperones. We find that in accordance with the fundamental
role of the chaperone system, chaperones are significantly more
ubiquitously and highly expressed across all tissues relative to
other protein-coding genes, and are also more important for
growth. Nevertheless, differential analysis of chaperone expres-
sion across tissues shows that most chaperones have tissue-
specific behaviors. A proteomic screen of mouse myoblasts cell
line and a computational analysis of chaperones with a known
aberration that is causal for a Mendelian disease show that these
tissue-specific behaviors tend to be conserved and functional. For
the community interested in specific chaperones we present a
website, https://netbio.bgu.ac.il/chapnet/, for browsing the infor-
mation on specific chaperones and their relationships across tis-
sues. We further highlight a core set of chaperones that is
uniformly expressed across tissues, and show them to be more
important for growth and more highly expressed than other
chaperones. This core subsystem establishes tissue-specific func-
tional networks, which are enhanced by their tissue-specific
relationships with other chaperones. Notably, by analyzing
transcriptomic datasets of human organ development42 and brain
aging37, we find that the core versus variable organization and the
tissue-specific functional networks are established throughout
development and are challenged in aging. We propose that the
combination of core and non-core chaperones constitutes a third-
level organization of the chaperone system that is capable of
supporting the different proteostatic demands of multi-cellular
eukaryotes, and that this organization illuminates the phenotypic
outcomes of chaperone aberrations.
Results
Chaperones are ubiquitously and highly expressed across
human tissues. We manually curated a list of chaperones and co-
chaperones of the main eukaryotic chaperone families, which
drive basic cellular processes needed in living cells. These inclu-
ded sHSP, HSP40, HSP60/HSP10, HSP70, HSP90, prefoldin, and
folding enzymes, as well as chaperones not structurally or func-
tionally associated with a specific chaperone family, such as ER
chaperones, which we denoted as “other” (see the “Methods”
section, Supplementary Data 1). Most of the chaperones in this
list were not substrate-specific. We also included the myosin
chaperone UNC45 and the collagen chaperone SERPINH1, since
they interact with multiple members of the myosin and collagen
protein families, respectively (Supplementary Data 1). To analyze
chaperone expression across tissues, we used RNA-sequencing
profiles of adult human tissues that were made available by the
GTEx consortium32. We focused on tissues with at least five
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available profiles sampled from donors with traumatic injury
fitting with sudden death, and avoided other death causes to limit
the effect of treatment, inflammation, and stress on chaperone
expression44–47. This resulted in a total of 29 tissues, 488 profiles,
and 194 expressed chaperones, co-chaperones and folding
enzymes, collectively referred to as chaperones (Supplementary
Data 1 and 2).
We first compared the distribution across tissues of expressed
chaperones to that of other protein-coding genes. We considered
a gene as expressed in a tissue if its median expression level in
samples of that tissue was above commonly used expression
thresholds (1, 5, or 10 transcripts per million (TPM), see the
“Methods” section). The number of chaperones expressed in each
tissue at a threshold of 1 TPM was similar (176 ± 6, Supplemen-
tary Data 2). Next, we associated each gene with the number of
tissues in which it was expressed (Fig. 1a, Supplementary Fig. 1A).
This resulted in a bi-modal distribution, as previously shown for
protein-coding genes48. However, chaperones were significantly
more broadly expressed than other protein-coding genes (p=
2.7E−9, Kolmogorov–Smirnov (KS) test, Fig. 1a). For example,
74% of the chaperones were expressed in all tissues, relative to
47% of the other protein-coding genes. Similar results were
observed with different TPM thresholds (Supplementary Fig. 1A).
Next, we examined the expression levels of chaperones relative
to other protein-coding genes. Within each of the 29 tissues that
we analyzed, the expression levels of chaperones were signifi-
cantly higher (p < 1.7E−7, Mann–Whitney (MW) test, Fig. 1b),
also upon considering other TPM thresholds (Supplementary
Fig. 1B). Since some chaperones are known to be upregulated in
stressful conditions, they could be driving the high expression
that we observed. To test for this, we defined a subset of 64 stress-
induced human chaperones, which were determined previously
by using a meta-analysis of microarray data38 (see the “Methods”
section). Indeed, stress-induced chaperones were more highly
Fig. 1 Chaperones are broadly expressed across human tissues. a The distribution of 194 chaperones, 130 non-stress-induced chaperones and 17,689
other protein-coding genes by the number of tissues expressing them at a level ≥1 transcripts per million (TPM; the first bin represents genes expressed in
a single tissue or two tissues, the second bin represents genes expressed in three or four tissues, etc.). Chaperones and non-stress-induced chaperones
were significantly more broadly expressed than other protein-coding genes (p= 2.7E−9 for both, two-sided Kolmogorov–Smirnov test). b The median
expression levels per tissue of chaperones, non-stress-induced chaperones and other protein-coding genes. Only genes expressed at a level ≥1 TPM were
considered. Chaperones and non-stress-induced chaperones tend to be significantly more highly expressed across all 29 tissues (adjusted p between 1.7E
−7 and 1.4E−19, and adjusted p between 0.026 and 4.9E−8, respectively, two-sided Mann–Whitney test). Chaperones n= 155–192; non-stress-induced
chaperones n= 102–129; other protein-coding genes n= 10,689–15,555. c The cumulative distribution of the impact on growth of 186 chaperones and
17,932 other protein-coding genes, measured in 769 cell lines harboring CRISPR-induced gene inactivation (CRISPR score). Each gene was associated with
its minimal CRISPR score. Chaperones were significantly more important for growth than other protein-coding genes (p= 1.5E−5, one-sided
Kolmogorov–Smirnov test). Source data are provided as a Source Data file.
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expressed than non-stress-induced chaperones (Supplementary
Fig. 1C). Nevertheless, upon excluding stress-induced chaperones
from the analysis, the remaining non-stress-induced chaperones
were still significantly more broadly expressed (p= 2.7E−9,
Fig. 1a and Supplementary Fig. 1A) and more highly expressed
than other protein-coding genes (p < 0.026, Fig. 1b and
Supplementary Fig. 1B). Finally, to validate the generality of
these observations, we repeated the above analyses by using
transcriptomic profiles of 37 human tissues that were made
available by the HPA30. The results obtained with this dataset
were similar to those obtained with the GTEx dataset, reinforcing
our conclusions (Supplementary Figs. 2A–C and 3).
To further examine to what extent chaperones are funda-
mental components of living cells, we utilized large-scale data
of gene essentiality from the DepMap project41. The DepMap
dataset measured the impact of CRISPR-induced individual
gene inactivation on growth rate in 769 human cell lines (see
the “Methods” section). We found that relative to inactivation
of other protein-coding genes, inactivated chaperones lowered
growth rates significantly, and were thus considered more
important for growth (p= 1.5E−5, KS test, Fig. 1c). The
relatively high impact of chaperones could be common to other
ubiquitously expressed protein-coding genes. However, upon
limiting our analysis to the subsets of chaperones and other
protein-coding genes that were ubiquitously expressed, chaper-
ones were still more important for growth (p= 0.0025, KS test,
Supplementary Fig. 1D). Similar results were obtained by using
gene essentiality scores in 318 cell lines from Project Score40
(Supplementary Fig. 4A, B). Altogether, chaperones appear to
constitute a ubiquitous and highly expressed cellular system
that is fundamental for cell growth.
Chaperone expression levels vary across human tissues. Despite
the ‘house-keeping’ functionality of chaperones, different tis-
sues have different folding, assembly, and maintenance
demands. For example, the demands of the sarcomere in muscle
cells, which contain titin, the largest protein in the human
body49,50 likely vary from those of synaptic neurotransmission
in neurons, where the membrane protein synaptic vesicle pro-
tein 2 (SV2) is amongst the most abundant and conserved
components51,52. Such demands become phenotypically
apparent in face of mutations. To test whether these demands
are met by tissue-specific chaperones, we gathered 62 tissue-
selective heritable disorders known to be caused by aberrations
in 43 distinct chaperones34,53,54, and analyzed the expression
patterns of these chaperones across tissues (see the “Methods”
section, Supplementary Data 3). In contrast to the tissue-
specific clinical manifestation of these disorders, most of the
43 underlying chaperones were expressed ubiquitously across
tissues (Fig. 2a), also when considering other expression
thresholds (Supplementary Fig. 1E), in agreement with the
behavior of other tissue-selective heritable disorders55,56. Thus,
chaperone disruption is harmful only in specific tissues, likely
depending on tissue folding demands.
Next, we asked whether the expression levels of each chaperone
remain high and uniform, or whether they vary across tissues. For
this, we computed the differential expression of chaperones in
any given tissue relative to all other tissues57 (see the “Methods””
section, Supplementary Data 4). Most chaperones (162, 83.5%)
had over 2-fold change in their expression in at least one
tissue, henceforth considered as variable chaperones. To display
the expression variability of chaperones across tissues, we
clustered chaperones and tissues hierarchically according to their
differential expression profiles (Fig. 2b). Physiologically related
tissues, such as skeletal muscle and heart, or different brain
tissues, clustered together, suggesting a biological relevance to the
differential expression patterns of chaperones.
To explore the biological relevance of tissue-specific differ-
ential expression profiles, we asked whether tissue-specific
changes in expression were related to tissue-specific pheno-
types. We focused on skeletal muscle, since it showed a distinct
differential expression profile relative to other tissues. Notably,
this distinct profile was not due to a higher number of
expressed chaperones in skeletal muscle relative to other tissues
(170 versus average of 176 chaperones, Supplementary Data 2),
or due to a high total expression of chaperones (11,604 TPMs
versus average of 14,283 TPMs).
We found that out of the 10 chaperones in which mutations
that cause disorders affecting skeletal muscle were identified
(Supplementary Data 3), seven chaperones were expressed at least
2-fold higher in skeletal muscle compared to other tissues (p=
0.0078, Fisher exact test, Fig. 2c). For example, DNAJB6 [log2 fold-
change (log2FC) of 2.24] and the NEF chaperone BAG3 (log2FC
of 3.13) lead to Limb-girdle muscular dystrophy 1E58 and
myopathies, respectively59–61. Mutations in the three remaining
chaperones (BCS1L, SIL1, and FKBP14) lead to diseases that affect
multiple tissues apart from skeletal muscle (Supplementary
Data 3). We also examined the remaining chaperones that were
upregulated in skeletal muscle for association with muscle disease
or function by literature mining. We found evidence for 31/50
chaperones (Supplementary Table 1), including 17 chaperones
that were associated with muscle diseases (e.g., HSPB8 with
myopathies) and 27 chaperones that were associated with muscle
function (e.g., the myosin chaperone UNC45B). Thus, chaperone
expression levels are likely designed to meet tissue-specific
demands, and consequently affect disease risks in a tissue-
specific manner.
A conserved chaperone expression pattern in muscle. Since our
analyses relied on transcriptomic datasets, which might not be
informative of tissue proteomes, we decided to test chaperone
expression patterns at the protein level. We first compared the
transcriptomic profile of skeletal muscle to a recently published
proteomic profile of the same tissue43. The two profiles correlated
significantly for chaperones and protein-coding genes (r= 0.61
and r= 0.37, respectively, p= 2.2E−16, Pearson correlation,
Supplementary Fig. 5A). Next, we asked whether this pattern is
conserved. For this, we profiled the proteome of the C2C12
mouse myoblast cell line before differentiation (day 0) and after
8 days of differentiation to myotubes (day 8, myotubes). A subset
of undifferentiated muscle cells (reserve cells) was used as a
control (day 8, reserve cells; Fig. 3a). We then compared the
differential proteomic profile of C2C12 cell line (day 8 myotubes
vs. day 0) to the differential transcriptomic profile of human
skeletal muscle. In support of the functional relevance and con-
servation of the GTEx muscle transcriptomic profile, the pro-
teomic and transcriptomic profiles were indeed correlated, both
upon considering all protein-coding genes (r= 0.65, p= 2.2E
−16, Pearson correlation, Fig. 3b) and upon considering cha-
perones alone (r= 0.47, p= 7.8E−5, Pearson correlation, Fig. 3c).
In contrast, no correlation was observed when we compared the
differential proteomic profile of reserve cells to the differential
transcriptomic profile of human skeletal muscle (Fig. 3d).
To substantiate the experimental results, we also compared
the proteomic profile of C2C12 myotubes to the transcriptomic
profile of skeletal muscle from the HPA30 (Supplementary
Fig. 5B), and to the proteomic profile of human skeletal
muscle43 (Supplementary Fig. 5C). The proteomic profile of
C2C12 myotubes indeed correlated with both datasets, though
to a lesser extent (Supplementary Fig. 5B, C). Lastly, we
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analyzed the expression of a subset of chaperones (10 sHSP
genes) using qPCR in an alternative muscle cell line model
consisting of cycling versus 5 days differentiated human
myoblasts (LHCNM2 cells62). Six of the seven sHSP that were
expressed at least 2-fold higher in skeletal muscle according to
the GTEx dataset were also upregulated in differentiated
LHCNM2 cells (Supplementary Fig. 5D). The three remaining
sHSP chaperones, which were not upregulated in skeletal
muscle according to the GTEx dataset, were also not
upregulated in differentiated LHCNM2 cells (Supplementary
Fig. 5D). These data provide further experimental support for
the conservation of the muscle-specific chaperone expression
pattern.
We further tested the functional conservation of muscle
chaperones by comparing between human and the evolutionary
distant multicellular organism Caenorhabditis elegans. We used a
set of C. elegans muscle chaperones19, and compared them to
human chaperones with C. elegans orthologs that were expressed
at least 2-fold higher in skeletal muscle relative to other tissues
(see the “Methods” section, Supplementary Table 1). We found
that the two subsets overlapped significantly (27 muscle
chaperones, p= 0.0009, Fisher exact test, Fig. 3e). For example,
Fig. 2 The variable expression of chaperones across human tissues. a The distribution of 43 chaperones with known aberrations that are causal for
Mendelian diseases by the number of tissues expressing them at a level ≥1 transcripts per million (TPM) or above (denoted heredity disease chaperones),
and the distribution of the respective 62 Mendelian diseases by the number of tissues in which they manifest clinically (denoted heredity diseases). We
united sub-parts of the same tissue (e.g., adipose subcutaneous and adipose visceral omentum were united into a single adipose tissue), ending up with
20 united tissues. Most hereditary diseases are highly tissue-specific (Supplementary Data 3). In contrast, hereditary disease chaperones are expressed
ubiquitously across tissues, also when considering other expression thresholds (Supplementary Fig. 1E). b A clustered heatmap showing the differential
expression of 194 chaperones across tissues. Differential expression of a chaperone in a tissue was computed by comparing the expression profiles of that
tissue to the expression profiles of all other tissues. Each entry reflects the log2 fold-change value (log2fc) of a chaperone (row) in a tissue (column); red
and blue denote positive and negative log2fc values, respectively. Physiologically related tissues often clustered together. c The overlap between 57
chaperones that were upregulated (log2fc≥ 1) in human skeletal muscle relative to other tissues, and the 10 chaperones with a known aberration that
causes heritable muscle disorders. Seven chaperones were both upregulated and associated with muscle disorders (p= 0.0078, one-sided Fisher exact
test). Source data are provided as a Source Data file.
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the HSP40 protein DNAJB6 had over 4-fold change in human
skeletal muscle and its C. elegans homolog, dnj-24, was highly
expressed in C. elegans body-wall muscle cells. Moreover, 23/27
orthologous muscle chaperones had a known association with
muscle folding, such as the myosin chaperone UNC45, and the
CCT subunits that are linked to actin folding (Supplementary
Table 1). Altogether, these observations suggest an inherent
requirement for chaperones in muscle tissue function that is
conserved in evolution.
Chaperone families show variable behavior across tissues. Since
members of each chaperone family share functional and struc-
tural attributes, we examined whether they also share expression
patterns. We focused on the tendency of chaperones for
ubiquitous expression, for variable expression across tissues, and
their impact on growth. To assess the ubiquitous expression of
each chaperone family, we recorded the number of tissues in
which chaperones were expressed (as in Fig. 1a, Supplementary
Data 1). Apart from sHSPs, all families were more ubiquitously
expressed than the rest of the protein-coding genes (adjusted p <
0.029, MW test). Members of the Prefoldin family and the ATP-
hydrolyzing chaperone families were ubiquitously expressed,
except for the HSP60 chaperonin that encodes a CCT subunit-
like protein, CCT8L2, which was expressed specifically in testis
(Supplementary Fig. 6A). Members of co-chaperone families
showed a more variable pattern, with both tissue-specific and
ubiquitously expressed members, except for NEFs (Supplemen-
tary Fig. 6A). These included, for example, the skeletal muscle-
Fig. 3 Chaperone expression in muscle tissue is evolutionary conserved. a The experimental pipeline. C2C12 mouse myoblast cell line was grown to 95%
confluency and differentiation was induced. After 8 days of differentiation, cells were separated to myotubes and reserve (undifferentiated) cells, and their
proteomes were analyzed using mass spectrometry (three biological replicates for each treatment were used). b The correlation between the differential
protein levels of 1561 proteins that were reliably measured in mouse myotubes vs. undifferentiated C2C12 cells, and the differential expression of their
homologous genes in human skeletal muscle (r= 0.65, p= 2.2E−16, Pearson correlation). c The correlation between the differential protein levels of 65
chaperones that were reliably measured in mouse myotubes versus undifferentiated C2C12 cells, and the differential expression of their homologous genes
in human skeletal muscle (r= 0.47, p= 7.8E−5, Pearson correlation). d The differential protein levels of 754 proteins that were reliably measured in
mouse reserve cells versus undifferentiated cells do not correlate with the differential expression of their homologous genes in human skeletal muscle (r=
0.06, Pearson correlation). e The overlap between 58 C. elegans muscle chaperones and 48 homologous chaperones that were up-regulated (log2fc≥ 1) in
human skeletal muscle (p= 0.0009, one-sided Fisher exact test). The 157 human chaperones with homologous genes in C. elegans were considered in the
analysis. Source data are provided as a Source Data file.
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specific coHSP90 chaperone UNC45B. sHSPs were more tissue-
specific than other chaperone families (adjusted p= 0.027,
MW test). In fact, sHSPs were also more commonly causal for
tissue-specific and neuro-muscular diseases63–68 (5/10 sHSPs,
Supplementary Data 3).
To assess the tendency of chaperone families for uniform vs.
variable expression across tissues, we associated each chaper-
one with the number of tissues in which it was variably
expressed (Supplementary Fig. 6B, Supplementary Data 1). All
families, except HSP70s and sHSPs, were expressed more
uniformly across tissues than the rest of the protein-coding
genes (adjusted p < 0.018, MW test). HSP60s and coHSP90s
were also expressed more uniformly than other chaperone
families (adjusted p ≤ 0.019, MW test). In contrast, sHSPs and
HSP70s were more variably expressed than other families
(adjusted p ≤ 0.033, MW test), with sHSPs also more variably
expressed than other protein-coding genes (adjusted p= 0.015,
MW test). Notably, HSP70 essential members, including the
main cytosolic member HSPA8, the ribosome-associated
member HSPA14, the ER member HSPA5 and the mitochon-
drial member HSPA9, were relatively uniformly expressed
(Supplementary Fig. 6B, Supplementary Data 1).
Lastly, we assessed the impact on growth of each family
(Supplementary Fig. 6C, Supplementary Data 1). Prefoldins,
HSP60s, HSP70s, and coHSP90s were more important for growth
than the rest of the protein-coding genes (adjusted p < 0.05, MW
test), and prefoldins and HSP60s were also more important for
growth than other families (adjusted p ≤ 0.045, MW test).
However, the impact of individual chaperones on growth was
highly diverse in most chaperone families. For example, most
CCT subunits were important for growth, yet CCT subunits such
as the testis-specific CCT8L2 and the variably expressed CCT6B
were less important. sHSPs were less important for growth than
other chaperone families (adjusted p < 0.066, MW test), fitting
with them having tissue-specific expression. In summary, whereas
certain features were family-based, members of most chaperone
families showed distinct features hinting to distinct functionalities
across tissues.
Core chaperones versus variable chaperones. We next focused
on the small subset of 32 (16%) chaperones that were expressed
uniformly across tissues, henceforth denoted as core chaperones.
Literature mining of the cellular processes in which these core
chaperones participate showed that they covered a variety of basic
processes, including de novo protein folding maturation and
assembly; ER-associated targeting, transport, folding, and degra-
dation; and translocation into the mitochondria (Fig. 4a). Core
chaperones were also slightly enriched for Prefoldins, CCTs, and
coHSP90s, and were depleted for sHSPs.
Next, we asked whether core chaperones included chaperones
with known heritable disease-causing aberrations (see the
“Methods” section). Only 3/32 core chaperones had such
aberrations, in contrast to variable chaperones, which were
significantly enriched for them (p= 0.04, Fisher exact test,
Fig. 4b). This suggests that core chaperones do not cause diseases,
either because core chaperones are functionally redundant, or,
inversely, because their aberration is embryonically lethal. One
such example is the CCT5 CRISPR knockout (Cct5em1(IMPC)Tcp)
mutant mice that showed preweaning lethality. To quantitatively
distinguish between the two alternatives, we compared between
the impact on growth of mutations in core and variable
chaperones69. We found that core chaperones were significantly
more important for growth than variable chaperones (p= 1.9E
−6, KS test, Fig. 4c, Supplementary Fig. 4C), also upon limiting
variable chaperone to those that were expressed ubiquitously
(p= 2.7E−12). Lastly, we compared the median expression levels
of core versus variable chaperones across tissues (Fig. 4d,
Supplementary Fig. 2D). Core chaperones were significantly
more highly expressed than variable chaperones (p < 2.2E−16,
MW test). Taken together, we propose that core chaperones
establish an essential subset of chaperones with stringent,
uniform demand across tissues.
Chaperone networks differ between tissues. Chaperones act as
part of a functional network. Previous studies analyzed the phy-
sical interactions of a subset of chaperones in tissue culture20 and
cancer cell lines70, or studied chaperones that were co-regulated
in cancer samples39 or in aging37. Yet, the functional network of
chaperones in physiological human tissues was rarely analyzed.
To examine this network, we focused on the co-expression of
chaperone pairs across tissues. For each pair of chaperones and
for each tissue, we computed the pairwise correlation between
chaperone expression levels across samples of that tissue (Sup-
plementary Data 5). We then constructed a heatmap presenting
these correlations for pairs composed of core chaperones (Fig. 5a)
and for mixed pairs composed of core and variable chaperones
(Supplementary Fig. 7A). Though core chaperones were uni-
formly expressed, their expression levels were not uniformly
correlated across tissues (Fig. 5a). In some tissues, such as heart
and brain, pairs showed similar and relatively high correlations.
However, in most other tissues, and more so among mixed pairs,
the correlations varied, suggesting that chaperones create tissue-
specific networks with distinct folding capacities.
To demonstrate this, we focused on the CCT complex, which
is composed of core and variable subunits (Fig. 5b). Again, we
found that in a subset of the tissues, a subset of CCT subunits
were highly correlated. Strikingly, CCT pairs that showed low
or anti-correlated expression were all mixed pairs (e.g., the
variable chaperones CCT6B or CCT8L2 with core chaperones).
These co-expression changes hint toward the functional
plasticity of the chaperone network across tissues. For example,
the core chaperone CCT5 was highly correlated with the
variable chaperone CCT6B specifically in testis (r= 0.89),
whereas in other tissues CCT5 was highly correlated with the
core chaperone CCT6A, the paralog of CCT6B (median
correlation 0.79; Fig. 5b). In agreement, CCT6B high levels
are specifically associated with testicular cancer, whereas high
levels of CCT6A are associated with a broad range of cancers71.
To quantify the tissue-specificity of functional relationship
between core–core versus mixed chaperone pairs at large-scale,
we associated each chaperone pair with the number of tissues in
which the pair was highly correlated (see the “Methods” section).
We found that the mixed relationships were significantly more
tissue-specific than core–core relationships (p= 6.2E−5, KS test,
Fig. 5c and Supplementary Fig. 7B), thereby giving rise to distinct,
tissue-specific functional networks.
To facilitate interrogation of the functional relationships
between chaperones across tissues, we created the ChaperoneNet
webtool (https://netbio.bgu.ac.il/chapnet/). Users can query
ChaperoneNet by chaperone and tissue, and obtain a graphical
network representation of the functional relationships of the
query chaperone in that tissue. The network highlights core
chaperones, marks chaperone families, and reports known disease
associations.
Consistent chaperone organization across development and
aging. To understand how fundamental is the chaperone orga-
nization that we observed in adult human tissues, we went on to
test whether it is maintained during human organ development.
To answer this question, we relied on a recent transcriptomic
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analysis of seven human organs, including brain (cerebrum),
cerebellum, heart, kidney, liver, ovary, and testis42. These organs
were profiled at 23 time points that ranged from early organo-
genesis (14 time points in weeks 4–20 post conception) to
adulthood. The study then associated each gene with measures
that represented its organ specificity, and with its time point
specificity in each organ (0 non-specific, 1 most specific). We first
compared between the organ and time point specificities of
chaperones versus other protein-coding genes. In accordance
with their ubiquitous expression in adult tissues, chaperones were
significantly more broadly expressed (i.e., non-specific) across
developing organs and across developmental time points in each
organ (p < 1.5E−14, MW test, Fig. 6a). Next, we tested whether
the distinction between core and variable chaperones was also
maintained. Indeed, relative to variable chaperones, core cha-
perones were significantly more broadly expressed across devel-
oping organs and across developmental time points in each organ
(p < 2.5E−4, MW test, Fig. 6a).
As part of the transcriptomic analysis of human organs during
development, genes were clustered per organ into modules
according to their developmental expression patterns. We
therefore asked whether chaperones that belonged to the same
module in development continued to function as a module in
adulthood. For this, we focused on six organs that were profiled
both during development42 and in adulthood32, including brain,
cerebellum, heart, liver, ovary, and testis. As shown in Fig. 6b,
except for ovary, chaperone pairs belonging to the same module
in development were significantly more correlated in adult
tissues, relative to chaperone pairs that did not belong to the same
module (p < 6.4E−8, MW test). Thus, chaperones belonging to
the same module continue to function as a module throughout
life. Interestingly, the correlations observed among core–core
pairs were generally higher than those observed among mixed
pairs; these, in turn, were higher than the correlations observed
among variable–variable pairs, suggesting a hierarchy of func-
tional relationships (Supplementary Fig. 8A). Taken together,
these data suggest that the core versus variable organization and
tissue-specific networks are consistent between developing organs
and adult tissues.
It is commonly acknowledged that the deterioration observed
in aging, particularly of the brain, involves reduced capacity for
proper protein folding, thereby leading to increased risk for
protein-misfolding neurodegenerative diseases, such as Alzhei-
mer’s and Parkinson’s diseases37,72. To illuminate the relationship
Fig. 4 The fundamental roles and impact of core chaperones. a The functional roles of the 32 core chaperones. Chaperones with several functions appear
in all categories that apply. Core chaperones performed basic function required by different cell types. b The overlap between core chaperones (top) or
variable chaperones (bottom), and chaperones with known aberrations that are causal for Mendelian diseases. Core chaperones tend to be depleted of
such chaperones, whereas variable chaperones tend to be enriched for them (p= 0.04, one-sided Fisher exact test). c The cumulative distribution of the
impact on growth of core (blue) versus variable chaperones (pink) measured in 769 cell lines harboring CRISPR-induced gene inactivation. 31 core and 155
variable chaperones for which CRISPR scores were available were considered. Each gene was associated with its minimal CRISPR score. Core chaperones
were significantly more important for growth (p= 1.9E−6, one-sided Kolmogorov–Smirnov test). d The median expression levels per tissue of core versus
variable chaperones (based on n= 928 and n= 4173 values, respectively). Core chaperones were significantly more highly expressed (p= 2.2E−16, one-
sided Mann–Whitney test). In the boxplot representation, center line, median; box limits, upper and lower quartiles; whiskers, 1.5× interquartile range.
Source data are provided as a Source Data file.
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between aging and the brain-specific chaperone network, we
relied on a large-scale analysis of chaperone expression in aging
brains37. There, pairs of chaperones with highly correlated
expression in aging brain were identified, and the expression of
each chaperone was tested for its correlation with age. To
examine whether the functional relationships between chaperones
were conserved in aging, we compared between highly correlated
pairs observed in adult brain and in aging brain. We found a
highly significant overlap between them (265 pairs, p= 1.4E−32,
Fisher exact test, Fig. 6c). Most of the overlapping pairs were
highly correlated only in brain and not in other tissues (167/265
pairs, Fig. 6c). Moreover, overlapping pairs belonged primarily to
modules that were repressed in aging brain37 (258/265). This
suggests that a brain-specific chaperone network is conserved
across time and is repressed with age.
Next, we focused on the main components of the brain-specific
chaperone network, namely core chaperones and variable
chaperones that were upregulated in adult brain, and examined
the change in their expression with age. We found that the
expression levels of both core chaperones and brain-upregulated
variable chaperones were generally reduced with age (Fig. 6d,
Supplementary Fig. 8B). In contrast, the expression levels of
variable chaperones that were not upregulated in brain did not
change in brain aging. This further suggests that the brain-required
chaperone system declines with age. Further decline in the brain-
required chaperone system was observed when we examined the
relative expression levels of chaperones in Alzheimer’s disease
patients versus age-matched controls37 (Fig. 6E). Taken together,
these results suggest a reduced protein-folding capacity of a brain-
specific chaperone system in aging that could contribute to age-
dependent neurodegeneration.
Discussion
Chaperones are basic components of all living organisms, and are
thus commonly regarded as house-keeping genes1. But, are all
folding environments similar to each other? In a multicellular
organism, owing to the specialized structures, functions, and
environments of the different cell types, folding requirements
could differ greatly. This raises the question of whether the
chaperone system is organized as a one size fits all, or whether the
requirements of each tissue are met by a tailored system. To
address this question systematically, we set out to examine the
expression landscape of molecular chaperones across physiolo-
gical human tissues.
We first examined the expression of chaperones across adult
human tissues, as measured via RNA-sequencing by the GTEx
consortium32. We determined that most chaperones were
expressed in all tissues, were highly expressed in most of them,
and were more important for growth than other protein-coding
genes, suggesting that they act as major building blocks across
all tissues (Fig. 1). Nevertheless, chaperones are also associated
with tissue-specific phenotypes, since germline aberrations in
ubiquitous chaperones or in ubiquitous aggregation-prone
proteins can lead to tissue-specific pathologies (Fig. 2a), such
as muscle disorders (Fig. 2c) or neurodegeneration63,73–75
(Fig. 6e). Indeed, we found that most chaperones were variably
expressed across tissues, suggesting that the chaperone system
is not simply common and consistent across tissues (Fig. 2b).
We did not consider substrate-specific chaperones, whose
expression likely correlates with the expression of their target
(for example, SERPINH1 expression is correlated with collagen,
Fig. 5 Functional relationships between chaperones differ across tissues.
a A heatmap of the expression correlations between core chaperones. Each
row corresponds to a distinct pair, and shows its expression correlation
values across tissues (columns). Across tissues, core chaperones modified
their co-expression relationships with each other, thereby creating tissue-
specific networks with distinct folding capacities. b A heatmap of the
expression correlations between CCT subunits. Each row corresponds to a
distinct pair, and shows its expression correlation values across tissues.
Mixed pairs of CCT subunits were less correlated in their expression across
tissues than core pairs. c The distribution of pairs of core chaperones (blue)
and mixed pairs of core and variable chaperones (pink) by the number of
tissues in which their expression levels were correlated (r > 0.7, Spearman
correlation). Pairs of core chaperones tend to be correlated across more
tissues relative to mixed pairs (p= 6.2E−5, two-sided Kolmogorov–Smirnov
test). Similar results were obtained using a different threshold
(Supplementary Fig. 7B). Source data are provided as a Source Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-22369-9 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:2180 | https://doi.org/10.1038/s41467-021-22369-9 | www.nature.com/naturecommunications 9
its client, in collagen-synthesizing cells76). The results of our
analyses are available as a webserver https://netbio.bgu.ac.il/
chapnet/ that can be queried by chaperone and tissue.
The GTEx transcriptomic resource allowed for high-resolution
tissue-specific analyses, yet was based on samples that were
collected from recently deceased donors. Consequently, the
observed chaperone levels might represent stressful conditions.
To test for this, we repeated analyses while excluding known
stress-induced chaperones (Fig. 1). We identified similar trends,
suggesting that the impact of stress is partial. Repeated analyses
by using the HPA transcriptomic dataset that covered 37 tissues
resulted in similar trends (Supplementary Figs. 2 and 3). A
limitation of these datasets is that transcript levels might not be
indicative of protein levels, as the general correlation between
them is not high43,77. Nonetheless, chaperone transcript levels
correlated with their protein levels in matched skeletal muscle
samples43 (Supplementary Fig. 5A). To further assess the rele-
vance of the transcriptomic profiles, we profiled the proteome of
a differentiating mouse myoblast cell line (Fig. 3a). Despite the
difference in measured molecules (transcripts versus proteins)
and species, we observed a strong agreement between the dif-
ferential transcriptomic profile of human skeletal muscle and the
proteomic profile of differentiated C2C12 mouse myotubes, but
not reserve cells (Fig. 3b–d). Agreement was also observed upon
comparing the proteomic profile of differentiated C2C12 mouse
myotubes to a proteomic profile of human skeletal muscle43
(Supplementary Fig. 5). Moreover, human chaperone genes that
were at least 2-fold differentially expressed in skeletal muscle by
GTEx were also enriched for C. elegans muscle chaperones
(Fig. 3e), and for chaperones causal for muscle disorders
(Fig. 2c), supporting the biological relevance of differential tissue
transcriptomic profiles.
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A small subset of chaperones, which we denoted as core, did
act as consistent building blocks across all tissues. Belonging to
fundamental cellular processes (Fig. 4a) this core subset was
more highly expressed relative to variable chaperones (Fig. 4d).
Core chaperones were also significantly more important for
growth than other chaperones (Fig. 4c), and ~2.5-fold less likely
to be causal for heritable disorders (9% versus 25%, Fig. 4b),
suggesting that they could be lethal when mutated in the
germline. Despite their consistent expression, core chaperones
had tissue-specific functional relationships both with other core
chaperones and with variable chaperones (Fig. 5a, b, Supple-
mentary Fig. 7A).
The existence of ubiquitously expressed chaperones was
previously suggested but not quantitatively demonstrated. An
aging-related subnetwork of chaperones was defined by the
impact of chaperone down-regulation on age-dependent neu-
rodegenerative models37. A comparison between our core
subset and the aging-related subset revealed an overlap of 10
chaperones (p= 8E−5, hypergeometric test, see the “Methods”
section) all of which were associated with de novo protein
folding or protein maturation. A second study identified an
epichaperome, which under stress conditions forms a network
of stable complexes that facilitate tumor survival70. A com-
parison between our core subset and this epichaperome
revealed an overlap of nine chaperones (p= 0.024, see the
“Methods” section), six of which were associated with signaling.
Taken together, the core set of chaperones that we defined is
multifaceted, and its dysregulation has pathological implica-
tions in neurodegeneration and cancer.
We tested the generalizability of the tissue-specific chaperone
organization across the time axis, focusing on human organ
development42 and brain aging37. Across developing organs and
time points, core chaperones were indeed more uniformly
expressed than variable chaperones (Fig. 6a). Moreover, func-
tional relationships among chaperones were generally maintained
in development (Fig. 6b) and in aging (Fig. 6c). Importantly,
focusing on brain aging, we found that brain-required chaper-
ones, including core and brain-upregulated chaperones, were
specifically downregulated with age (Fig. 6d), and further
decreased in Alzheimer’s disease patients (Fig. 6e). These analyses
suggest that the tissue-specific organization of the chaperone
network is established in organ development, maintained through
adulthood, and is challenged in aging. This organization could
therefore contribute to tissue-specific phenotypes and age-
dependent diseases.
Altogether, our analyses expose a novel layer of functional
organization: Core chaperones, involved in basic cellular
function shared by all cell-types, behave more like a one size fits
all, whereas variable chaperones respond to tissue-specific
demands and behave as a tailored system. We thus expand
the previous functional view of chaperones, whereby the tran-
sition between prokaryotes and eukaryotes separated stress
induced from constitutive chaperones28. We propose that the
transition to multi-cellularity further separated constitutive
chaperones into core and variable chaperones, allowing for the
modulation of the chaperone system in a tissue-dependent
manner (Fig. 7).
The functional organization of chaperones is likely associated
with their transcriptional regulation across tissue. In unicellular
eukaryotes, chaperones required for de novo folding, such as CCT
or Prefoldin subunits and ribosome-associated HSP70, were
transcriptionally and functionally linked to the translational
machinery28, as might still be the case for certain core chaper-
ones. Variable chaperones, in contrast, might be upregulated by
tissue-specific transcription factors. In support, neuronal stem
and progenitor cell differentiation was shown to rewire the cha-
perone network78. Likewise, the main muscle differentiation
transcription factor, MYOD1 (HLH-1 in C. elegans), was shown
to drive the expression of chaperones in C2C12 mouse myoblast
cell line and C. elegans muscle19,79,80.
Chaperones tissue-tailored organization could offer an
explanation for the tissue-specificity of heritable chaper-
onopathies and protein-misfolding diseases73,75,81. These dis-
eases manifest clinically in few tissues, although most genes and
chaperones whose aberrations lead to disease are expressed
ubiquitously (Fig. 2a)34,53,55. In some cases, this could be due to
the overexpression of such genes in their disease-manifesting
tissue34,55,56,82, as we observed for muscle diseases (Fig. 2c). We
Fig. 6 Chaperones organization is conserved in organ development and brain aging. a Organ specificity and organ time point specificity of protein-coding
genes (16,955 genes) and chaperones (31 core and 156 variable genes). Specificity values ranged between 0 (non-specific expression) and 1 (specific
expression). Across organs and time points, chaperones were more ubiquitously expressed than protein-coding genes, and core chaperones were more
ubiquitously expressed than variable chaperones. Adjusted p-values for organ specificity and time point specificity in brain, cerebellum, heart, kidney, liver,
ovary, and testis, in respective order: chaperones versus protein-coding genes: p= 4.8E−16, 3.24E−18, 7.26E−17, 8.16E−20, 1.48E−14, 3.2E−21, 3.27E
−15, 1.9E−20; core versus variable chaperones: p= 5.39E−10, 4.5E−5, 1.4E−4, 2.5E−4, 1.4E−4, 6.44E−5, 3.53E−5, 1.23E−7 (one-sided Mann–Whitney
test, Benjamini–Hochberg correction). Chaperones n= 187, 180, 171, 178, 176, 176, 177, 184; protein-coding genes n= 16,955, 14,517, 14,017, 13,828, 14,136,
13,854, 13,988, 15,712; core chaperones n= 31; variable chaperones n= 156, 149, 140, 147, 145, 145, 146, 153. b Expression correlation values in adult
tissues for chaperone pairs whose pair-mates share, or do not share, a developmental module. Except for ovary, pairs belonging to the same developmental
module were more highly correlated than other pairs. Adjusted p-values for brain, cerebellum, heart, liver, and testis, in respective order: p= 3.14E−14,
6.33E−8, 4.7E−79, 8.6E−27, 3.5E−231 (one sided Mann–Whitney test, Benjamini–Hochberg correction). Pairs in same module n= 916, 1204, 862, 694,
1818; pairs in other modules n= 16,851, 16,563, 16,904, 17,072, 15,948. c Consistency between chaperones that were highly correlated (r > 0.8) in adult
brain (n= 2014 pairs) and in aging brain (n= 1193 pairs) is shown by their significant overlap (265 pairs, p= 1.4E−32, one-sided Fisher exact test). The
distribution of the 265 consistent chaperone pairs by the number of non-brain tissues in which they were highly correlated reveals that most of them were
brain-specific, i.e., were not highly correlated in any other tissue. d The correlation between chaperone expression levels in prefrontal cortex and age is
shown for core chaperones (n= 26), variable chaperones that were upregulated in adult brain (n= 78), and variable chaperones that were not upregulated
in brain (n= 73, other). Expression levels of core and brain-upregulated chaperones decreased with age. The expression levels of other variable chaperones
did not change (see Supplementary Fig. 8B for additional brain regions). The difference between the two subsets of variable chaperones was statistically
significant (p= 6.9E−6, one-sided Mann–Whitney test). e Relative expression levels of chaperones in patients with Alzheimer’s disease and controls is
shown for core chaperones (n= 26), variable chaperones that were upregulated in adult brain (n= 78), and remaining variable chaperones (n= 73, other).
Expression levels of core and brain-upregulated chaperones decreased in patients, whereas expression levels of remaining variable chaperones did not
change. The difference between the two subsets of variable chaperones was statistically significant (p= 4.12E−6, one-sided Mann–Whitney test). In the
boxplot representation, center line, median; box limits, upper and lower quartiles; whiskers, 1.5× interquartile range; points, outliers. Source data are
provided as a Source Data file.
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propose that it could also stem from chaperones collaborating
or competing with each other over substrates, thereby leading
to a proteostatic environment that is limiting to other
proteins83–87. Since the levels of chaperones and substrates are
altered between tissues, and since these alterations are func-
tional, the proteostatic environment could both contribute to
tissue-specific functionality and elicit tissue-specific phenotypes
when perturbed, thereby giving rise to tissue-specific protein
misfolding diseases. Targeting ubiquitously expressed chaper-
ones can give rise to non-specific effects and has therapeutic
limits88. Our results can help direct efforts toward chaperones
that are more sensitive to cell-specific modulation of their
expression, and thus might be better suited as potential ther-
apeutic targets for cell-specific diseases. Formulating and
quantifying the function of the chaperone system at large scale
and within single cells is therefore one of the main challenges in
proteostasis research.
Methods
Curation of an integrated list of human chaperones. We compiled a curated list
of 195 known human chaperone, co-chaperone, and folding enzyme genes, col-
lectively named chaperones (Supplementary Data 1). For that, we compared two
curated lists of human chaperones: (1) a list of 332 chaperones curated by con-
sidering their biochemical properties and protein domains37; and (2) a list of 194
chaperones complied based on sequence homology to conserved canonical cha-
perones and supplemented by a list of known co-HSP90 chaperones6,89. These lists
included 114 genes belonging to well-conserved chaperone families, including sHsp
(10 genes), HSP60/HSP10 (15 genes), HSP70 (13 genes), HSP90 (4 genes), Pre-
foldin (9 genes), and co-chaperones Hsp40 (49 genes) and NEFs (14 genes). 106 of
these chaperones appeared in both lists (~93% overlap). Less agreement between
the lists was observed for the co-Hsp90 family, where only 24 (19%) chaperones
out of 127 putative co-HSP90 chaperones appeared in both lists. This inconsistency
was due to the lack of a conserved domain shared by all members of the co-HSP90
family, and uniquely by them. For example, many known co-HSP90 chaperones
have a tetratricopeptide repeat (TPR) motif, but not all TPR-containing proteins
are chaperones90. We therefore included 34 co-HSP90 chaperones that were pre-
viously shown to interact or function with HSP9015,91,92, three of which did not
appear in any list and 22 appeared in both lists (~71% overlap). The remaining
genes in the initial lists6,37,89, denoted as ‘others’, included members such as ER
chaperones, mitochondrial chaperones, AAA+ proteins and folding enzymes. For
each member, we mined the literature to determine whether it functions as a
chaperone that transiently assists the folding, unfolding, assembly or disassembly of
proteins and protein complexes. For example, we excluded eight nuclear cyclo-
philins that appeared in both lists, as these were recently shown to constitute an
integral part of spliceosomal complexes and were renamed as spliceophilin93. Of
the 47 chaperones that we included as ‘others’, 30 appeared in both lists (~64%
overlap). Finally, we excluded genes that were annotated as pseudogenes or as
noncatalytic proteins. For example, of the six HSP90 family genes, we excluded two
pseudogenes (HSP90AA2 and HSP90B2P). Out of the 195 chaperones, only
PPIAL4A did not meet the expression threshold of 1 TPM in any tissue and was
therefore omitted from further analyses.
Additional chaperone subsets. We annotated the functionality of core chaper-
ones by manual curation of their Uniprot entries94 and by literature search. Data of
curated, muscle chaperones in C. elegans were obtained from ref. 19. Data of
orthologous chaperones in C. elegans were obtained via the OrthoList2 tool for
comparative genomic analysis between C. elegans and humans95, and each human
chaperone was fitted with the C. elegans gene(s) that was identified as its ortho-
logue by the maximal number of programs. Data of orthologous chaperones in
mouse were obtained from Mouse Genome Informatics (MGI) website96.
Genes with a known genetic aberration that is causal for heritable diseases were
obtained from OMIM54, and limited to genes with a known genetic basis regardless
of their mode of inheritance. Manually curated data of the tissues that clinically
manifest a Mendelian disease were obtained from ref. 53. We additionally mined
the literature for chaperones that are causal for or associated with muscle disorders
or muscle function (Supplementary Data 3 and Supplementary Table 1).
Chaperones that are induced by stress were obtained from a meta-analysis study
of several microarray datasets of stress-induced genes89.
Comparison to additional functional subsets. An aging-related subnetwork of
chaperones was defined previously by the impact of chaperone down-regulation on
age-dependent neurodegenerative models37. The study included 187 chaperones, of
which 20 were core chaperones. 28/187 were considered as an aging-related subset,
including 10 core chaperones (p= 8E−5, hypergeometric test). The 10 core cha-
perones included 6 CCT subunits, HSPA14, DNAJA1, HSP90AA1 and its cocha-
perone STIP1. A cancer-related study identified an epichaperome, which under
stress conditions forms a network of stable complexes that facilitate tumor
survival70. The study included 63 chaperones, of which 13 were core chaperones.
26/63 chaperones formed the epichaperome, including 9 core chaperones (p=
0.024, hypergeometric test). These included HSP90AA1 and its co-chaperones
(DNAJC7, AHSA1, NUDC, SGTA, STIP1, SUGT1), as well PFDN2, DNAJA1. The
core chaperones DNAJA1, HSP90AA1, and its cochaperone STIP1, were part of
both the aging-related and the epichaperome subsets.
Human gene expression dataset. Data of transcriptomic profiles of human tis-
sues measured via RNA-sequencing were downloaded from the GTEx portal
(version 7). We analyzed samples from donors with traumatic injury fitting with
sudden death, and avoided other death causes to limit the effect of treatment and
stress on chaperone expression44–47. We considered only physiological tissues (i.e.,
no transformed cells) with ≥5 samples. Brain sub-tissues were collapsed into three
main regions including brain basal ganglia, largely cortex, and brain other,
according to Paulson et al. 97. Altogether, we analyzed 488 transcriptomic profiles
and 29 tissues (Supplementary Data 2). Genes were mapped to their Ensembl gene
identifiers using BioMart98, and filtered to include only protein-coding genes. Data
of gene expression pattern during organ development was extracted from ref. 42,
and included organ and timepoint specificity scores per gene, and module asso-
ciation per gene and organ. Data of chaperone expression in aging brain were
extracted from ref. 37, and included, per chaperone, a correlation between its
expression and age, a ratio between its expression in patients with a neurode-
generative disease and age-matched controls, its module association, and a list of
highly correlated chaperone pairs. To verify the trends observed with the GTEx
dataset, we used transcriptomic profiles of 37 human tissues measured via RNA-
sequencing by the HPA30. Expression values in protein TPM (pTPMs) units were
downloaded from the HPA portal.
Gene expression analyses. To analyze the expression pattern of genes across
tissues, we considered genes as expressed in a tissue if their median expression
level was ≥1 TPM. Results pertaining to expression thresholds of 5 or 10 TPM
are presented in Supplementary Fig. 1 and Supplementary Fig. 3. The differential
expression of genes per tissue was calculated as in ref. 57. Raw reads were
normalized to obtain the same library size for every sample by using the trim-
med mean of M-values (TMM) method by the edgeR package99. Genes with ≤10
raw counts per sample across all samples were removed before normalization. In
Fig. 7 A layered architecture of chaperones across unicellular and
multicellular organisms. The chaperone system of E. coli is composed of
constitutive chaperones that can be induced upon stress (left). The
chaperones system in yeast diverged to include chaperones that are either
constitutive or stress-induced (middle). In multi-cellular organisms such as
human, the chaperone system diverged further to also include core
chaperones that are stable across tissues and variable chaperones that are
differentially expressed across tissues (right), thereby giving rise to tissue-
specific expression patterns, for example in brain, lung, or muscle.
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each sample, we transformed the normalized counts profile using the voom
method100. To compute the differential expression of genes in a given tissue
relative to their expression in other tissues, we compared all transformed profiles
of that tissue to a background set containing transformed profiles of all other
tissues. Differential expression of genes in a tissue relative to other tissues was
then calculated by using the Limma linear model101. The differential expression
of a gene in a given tissue was then set to its log2 fold-change value in that tissue,
and the p-value was adjusted for multiple hypothesis testing via
Benjamini–Hochberg correction. We considered genes with an absolute log2
fold-change ≥1 and adjusted p-value ≤ 0.05 as differentially or variably expres-
sed. We defined core chaperones as chaperones that across all tissues had less
than a 2-fold change in their expression. In the comparison between organ
development and adult tissues, cerebrum and cerebellum were compared to
brain 1 and brain 2, respectively. In the analyses of chaperone expression in
different regions of the aging brain and in patients with neurodegenerative
diseases versus controls, brain regions were matched with brain 1 for calling
upregulated and downregulated variable genes.
Impact on growth analyses. The impact on growth score of a gene was measured
by the change in growth rate of a cell line containing a CRISPR-induced inacti-
vation of the gene relative to control69, denoted as CRISPR score of the gene. A
negative (or positive) gene value implied a reduced (or increased) growth rate of its
respective CRISPR-inactivated cell line relative to control; genes with negative
values were considered important for growth of the respective cell lines. Data of
CRISPR scores were obtained from DepMap41 and from Project Score40, via the
Broad Institute’s DepMap portal (https://depmap.org). DepMap data were avail-
able for 186 chaperones across 769 cell lines. Project Score data were available for
185 chaperones across 318 cell lines. Analyses were performed using data from
DepMap. We repeated them using data from Project Score, which led to similar
results (Supplementary Fig. 4).
Statistical analyses. To test the null hypothesis that the expression levels across
tissues of chaperones and protein-coding genes were drawn from the same
distribution we used the KS test. We used the same test to compare between the
impact of growth values of chaperones and protein-coding genes. To test the null
hypothesis that gene expression levels of chaperones and protein-coding genes
are similar, we used the MW U test. To test the null hypothesis that the impact of
growth values of chaperones were similar to those of other protein-coding genes,
we considered per gene its minimum CRISPR score across cell lines per project,
and applied the KS test. To compute the statistical significance of the overlap
between different gene sets we used Fisher exact test. Upon analyzing ortholo-
gous chaperones and the significance of the overlap, we considered all human
chaperones in our data that had an orthologue in the respective species. To
assess the correlation between the differential expression of human genes and
mouse proteins in muscle samples we computed their Pearson correlation. To
test the null hypothesis that organ and time point specificities were similar
between chaperones and protein-coding genes, or between core and variable
chaperones, we used the MW U test. The same test was used to check the null
hypothesis that chaperone pairs have similar correlated expression in adult
tissues, whether they belong to the same developmental module or not. p-values
were adjusted for multiple hypothesis testing by using Benjamini–Hochberg
procedure.
Coexpression analyses. For each pair of chaperones and each tissue, we calculated
the Spearman correlation between the expression levels of the two chaperones
across all samples of that tissue. These correlations were viewed as a heatmap
(Fig. 5 and Supplementary Fig. 7).
ChaperoneNet implementation. The ChaperoneNet server was implemented in
Python by using the Flask framework with data stored on a MySQL database. The
website client was developed using the ReactJS framework and designed with
Semantic-UI. The network view is displayed by the cytoscape.js plugin102. The
website supports all major browsers. Recommended viewing resolution is 1440 ×
900 and above.
Cell cultivation of C2C12 mouse myoblast cell line and RT-qPCR analysis.
C2C12 cells (ATCC CRL1772) were grown in Dulbecco’s modified Eagle medium
(DMEM) containing 10% fetal bovine serum (FBS), penicillin/streptomycin
(0.1 mg/mL) and L-glutamine (2 mM). For differentiation, cells were grown to 95%
confluency and medium was changed to differentiation medium, containing 4%
donor horse serum (DHS) instead of FBS. During differentiation, the medium was
changed at least every other day. Cells were harvested after 8 days, when they
reached maximal differentiation. To separate myotubes from reserve cells, we used
the property of myotubes to detach from cell culture plates under milder condi-
tions than reserve cells. Plates were washed with PBS and incubated with trypsin
diluted in DMEM medium without additives until most myotubes started
detaching. Myotubes were then washed off the plate using PBS buffer. The
remaining reserve cells were detached using 0.25% Trypsin and 0.05% EDTA
solution. Both myotubes and reserve cell fractions were washed twice with 10 mL
PBS and kept at −80 °C. To verify that C2C12 myotubes did differentiate, the
expression of several gene markers, including myosins, MYH3, MYOM1, and
chaperones, HSPB7 and UNC45B, was determined. Total RNA was purified using
GENEzol TriRNA Pure Kit (Geneaid) and DNase I DNA-free DNA removal Kit
(Invitrogen). First-strand cDNA was generated using Iscript cDNA Synthesis Kit
(Biorad) for real-time PCR (qPCR). For each reaction 1 µg of total RNA was used.
The cDNA was stored at −20 °C or used immediately. cDNA was amplified in
CFX96 C1000 Thermal cycler (Bio-Rad) using KAPA SYBR FAST Kit (Sigma). For
each reaction 20 ng of cDNA was used. The real-time PCR was performed as
follows: one cycle of denaturation (95 °C for 3 min) followed by 40 cycles of
amplification (95 °C for 3 s, 60 °C for 30 s). Each reaction was monitored by the use
of a negative control (no template). DNA amounts were quantified using the ΔΔCt
method, normalizing to the housekeeping gene Hprt1. MW test was used for
comparisons between myotubes or reserve cells to control (Supplementary Fig. 5E).
A list of primers used is detailed in Supplementary Table 2.
C2C12 mouse myoblast cell line mass-spectrometric analysis. The proteome of
C2C12 mouse myoblast cell line before differentiation (day 0); after 8 days of
differentiation to myotubes (day 8, myotubes); and of undifferentiated muscle
cells (day 8 reserve cells) were analyzed using LC–MS/MS (n= 3 biological
repeats for each treatment; Technion, Israel). Cells were suspended with 9 M
urea and 10 mM DTT solution and sonicated with a Cup-Horn sonicator for
2 min with 10 s on and off cycles. After centrifugation to remove cell debris,
samples were digested by trypsin (Promega) at a 1:50 enzyme-to-substrate ratio,
overnight at 37 °C with an additional trypsinization done for 4 h. The tryptic
peptides were desalted using C18 tips (Top tip, Glygen) dried and re-suspended
in 0.1% formic acid. The resulted peptides were analyzed by LC–MS/MS using a
Q-Exactive plus mass spectrometer (Thermo) fitted with a capillary HPLC (easy
nLC 1000, Thermo-Fisher). The peptides were loaded onto a C18 trap column
(0.3 × 5 mm, LC-Packings) connected on-line to a homemade capillary column
(20 cm, 75 micron ID) packed with Reprosil C18-Aqua (Dr. Maisch GmbH,
Germany) in solvent A (0.1% formic acid in water). The peptides mixture was
resolved with a (5–28%) linear gradient of solvent B (95% acetonitrile with 0.1%
formic acid) for 180 min followed by gradient of 15 min gradient of 28–95% and
25 min at 95% acetonitrile with 0.1% formic acid in water at flow rates of
0.15 μL/min. Mass spectrometry was performed in a positive ion mode (at mass
range of m/z 350–1800 AMU and resolution 70,000) using repetitively full MS
scan followed by collision induces dissociation (HCD, at 35 normalized collision
energy) of the 10 most dominant ions (>1 charges) selected from the first full
MS scan.
The mass spectrometry data was analyzed using the MaxQuant software 1.5.2.8.
(www.maxquant.org) for peak picking identification and quantitation using the
Andromeda search engine, searching against Mus musculus part of the Uniprot
database (June 2015) with mass tolerance of 20 ppm for the precursor masses and
20 ppm for the fragment ions. Trypsin was set as the protease. Methionine
oxidation and acetylation of protein N-term were accepted as variable
modifications and carbamidomethyl on cysteine was accepted as static
modification. Minimal peptide length was set to six amino acids and a maximum of
two miscleavages was allowed. Peptide-level and protein-level false discovery rates
(FDRs) were filtered to 1% using the target-decoy strategy. The protein table was
filtered to eliminate the identifications from the reverse database, and common
contaminants. The data was quantified by label free analysis using the MaxQuant
software, based on extracted ion currents (XICs) of peptides enabling quantitation
from each LC/MS run for each peptide identified in any of experiments. Welch’s t-
test was performed on the log2 of the LFQ Intensity values using Perseus software.
We used only mouse proteins whose expression was measured at day 0 and day 8
and that showed significant differences, and their human homologs. In the
comparison to protein abundance in human skeletal muscle43, human proteins
were associated with their median raw protein abundance across skeletal muscle
samples.
Cell cultivation of LHCN-M2 human myoblast cell line and RT-qPCR analyses.
LHCN-M2 (cycling human myoblasts) cells were described elsewhere103. The cells
were maintained in Ham-F12 supplemented with 100 U/mL penicillin/strepto-
mycin, 20% FBS, and 25 ng/mL of rhFGF-b/FGF-2. For induction of myogenic
differentiation, LHCN-M2 cells were cultured in DMEM supplemented with
100 U/mL penicillin/streptomycin, and 30 μg/mL human insulin solution for
5 days. Cells were routinely tested for mycoplasma contamination.
For gene expression analysis in LHCN-M2 cells, total RNA was isolated using
Trizol, followed by purification using RNA Clean & Concentrator (Zymo Research,
USA) and DNase I Set (Zymo Research, USA). First-strand cDNA was generated
using Maxima First Strand cDNA Synthesis Kit for RT-qPCR (ThermoFisher). For
each reaction 1 µg of total RNA was used. The samples were incubated at 25 °C for
10 min followed by a step of 50 °C for 15 min, and then 85 °C for 5 min. The cDNA
was stored at −20 °C or used immediately for RT-qPCR. cDNA was amplified in
CFX96 Touch Thermal cycler (Bio-Rad) using TAQ SYBR Green qPCR SYBR
(ThermoFisher). For each reaction 50 ng of cDNA was used. RT-qPCR was
performed as follows: one cycle of denaturation (95 °C for 3 min) followed by 40
cycles of amplification (95 °C for 10 s, 60 °C for 30 s). Each reaction was monitored
by the use of a negative control (no template). DNA amounts were quantified using
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the ΔΔCt method, normalizing to RPL0and the cycling condition was set to 1. A
list of primers used is detailed in Supplementary Table 2. Student’s t-test was used
for comparisons between two groups.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Code availability
Data of chaperones analyzed in the study are available as Supplementary Data 1. Data of
tissues analyzed in the study appear in Supplementary Data 2. Data of disease-
associated chaperones appear in Supplementary Data 3. Data of expression fold-change
of chaperones across tissues is available as Supplementary Data 4. Data of pairwise
chaperone co-expression correlations per tissue are available as Supplementary Data 5,
and through the ChaperoneNet webtool (https://netbio.bgu.ac.il/chapnet/). The mass
spectrometry proteomics data were deposited in ProteomeXchange Consortium via the
PRIDE104 partner repository with the dataset identifier PXD022678 (LC–MS/MS of
C2C12 mouse myoblast cell line). The analyzed mass spectrometry proteomics data of
mouse myoblasts are available as Supplementary Data 6. Source data for Figs. 1–6 are
provided with this paper. The following databases were used in the study: GTEx v7
http://www.gtexportal.org/home/; The Human Protein Atlas http://www.proteinatlas.
org; Mouse Genome Informatics http://www.informatics.jax.org/; BioMart http://m.
ensembl.org/biomart/martview; OMIM http://www.omim.org/; and DepMap http://
depmap.org.
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